This is the supplier profile page of Zhejiang Aoxing Biotechnology Co., Ltd, where buyers can explore products, connect directly with the supplier for pricing inquiries.

Add Favorite

|

Report Supplier

|
This business has not been verified yet.
If you are the business owner, verify now to manage this profile and connect with verified buyers. Verify Now

Business Description

Founded in 1997, Zhejiang AOXING Biotechnology Co., Ltd. is the largest manufacturer for chitin derivates and marine biology series products. In addition, it possesses several wholly-owned subsidiaries and holding companies, including Jiangsu AOXIN Biotechnology Co., Ltd., Wuhan AOLVXIN Biotechnology Co., Ltd., Yuhuan AOXING International Trade Co., Ltd., British Healthcare Warehouse Pharmaceutical Co., Ltd., Australian Betaflex Co., Ltd., Lianyungang XINERNA Chemicals Co., Ltd., and AOXIN TMALL.Zhejiang AOXING Biotechnology Co., Ltd., as a €œHigh and New-tech Enterprise in Zhejiang Province€, possesses RMB 50 million Yuan of capitals and covers an area of 90,000 ㎡. It is occupied in R&D, production, and domestic and overseas sales of chitin derivates, chitosan series, glucosamine, N- acetylglucosamine series, chondroitin sulfate series, collagen series, and marine biomedical materials for a long term. In addition, it possesses modern GMP production workshops, advanced testing devices, and labs, as well as a batch of high and new-tech products and several patents for invention with proprietary intellectual property rights. €œAOXING€ trademark has been rated as €œa Famous Trademark in Zhejiang Province€.Jiangsu AOXIN Biotechnology Co., Ltd. invested by Zhejiang AOXING Biotechnology Co., Ltd. with RMB 62 million Yuan in National Medicine High and New Industrial Park of Lianyungang City, possesses the largest glucosamine production workshops in China. In addition, the company has had backbone talents in science and technology made up of doctors of biology and medicine and senior engineers, and at the same time, it has established united labs with some academic institutes, including Ocean University of China, Wuhan University, and Jiangsu Marine Resources Development Research Institute. Comprehensive R&D ability of the company in health care products raw materials, intermediates, bulk pharmaceutical chemicals, and preparations has achieved domestic advanced level.Located in Biology City, National High and New District, Donghu Lake, Wuhan, and founded in 2012, Wuhan AOLVXIN Biotechnology Co., Ltd. is the second largest holding subsidiary of Zhejiang AOXING Biotechnology Co., Ltd. In addition, it is mainly engaged in production and R&D of chitosan biological dressings and medical materials. The factory has passed GMP inspection and applied for national category-2 medical device approval number.British Healthcare Warehouse Pharmaceutical Co., Ltd., Yuhuan AOXING International Trade Co., Ltd., and Australian Betaflex Co., Ltd., as wholly-owned subsidiaries, are mainly occupied in developing and selling healthcare raw-food materials and medical intermediates in world market.With continuous development and expansion, AOXING will provide stages for more people to show talents, inherits dreams and passion, receive the AOXING spirit of €œdown-to-earth, hard-fighting, innovative, and superior€, and march toward a new journey.

Trade Capabilities

Business Terms

Preferred Payment Term:

Not specified

Preferred Trade Term:

Not specified

Port Of Loading:

Not specified

Accepted Currency:

USD

Trade Ability

Annual Revenue Amount:

Not specified

Numbers Of Employees:

Not specified

Avg Response Time:

-

Products / Services Offered

Register Banner